Management of Treatment-Related Adverse Events Symposium - On Demand


Management of Treatment-Related Adverse Events Symposium - On Demand Banner



Date & Location
Friday, February 5, 2021, 7:45 AM - Friday, December 31, 2021, 12:15 PM

Specialties
Specialties - Allergy and Immunology, Cardiology, Dermatology, Dermatopathology, Emergency Medicine , Endocrinology, Diabetes and Metabolism, Gastroenterology, Gastrointestinal Oncology, Genitourinary Oncology, Geriatric Medicine, Gynecologic Oncology, Integrative Medicine, Medical Oncology, Neuro-Oncology, Solid Tumor Oncology

Overview

MSK CME is pleased to offer an on demand option for the Management of Treatment-Related Adverse Events Symposium, which was recorded October 23-24, 2020.

Systemic anticancer therapies (cytotoxic chemotherapies, targeted therapies, immunotherapies) have resulted in remarkable improvements in patient survival. Despite this remarkable success, the majority of patients will develop toxicities of various organ systems, which may impact overall health and activities of daily living, resulting in inconsistent antineoplastic therapy, all of which may affect clinical outcome. Therefore, prevention and management of untoward events is critical for the maintenance of quality of life and the optimization of anticancer therapies.

Symposium Highlights

  • Therapy-related adverse events will affect the majority of cancer patients, resulting in increased cost, inconsistent dosing, and decreased quality of life.
  • With increased survival and patients living longer on therapy, adverse events affecting quality of life and clinical outcome command attention.
  • Lectures focused on immune-related adverse events will describe the clinical presentation, diagnosis, and management strategies for the oncology healthcare provider.
  • Up-to-date information will be presented on adverse event mechanisms and management from specialists in the most commonly affected organ systems.
  • Practical strategies to identify patients at high risk will be highlighted, with strategies to direct patients towards the most efficient therapies based on healthcare providers.
  • New strategies to monitor and manage symptoms of patients on active anticancer treatment will be discussed including patient-reported outcomes and tele-oncology visits.

The target audience for this program includes MDs, PAs, NPs, RNs, Pharmacists, and other healthcare professionals treating cancer patients and their associated symptoms.

This on demand program is endorsed by the Multinational Association of Supportive Care in Cancer.



Objectives
  1. Recognize the clinical presentation and impact on quality of life of treatment-related adverse events
  2. Understand mechanisms to identify and triage patients at high risk for the development of toxicities
  3. Discuss procedures and clinical strategies to prevent and treat adverse events in patients with cancer

Registration

By registering for this on demand program, you will receive access to videos from the two day course, which was originally recorded on October 23-24, 2020, as well as PDFs of the speaker presentations. Once you are successfully registered, click on the 'Course Content' tab at the top of this page and follow the instructions. 

This on demand program will be available for purchase until December 31, 2021.
Access to the videos and claiming credit will be available until March 31, 2022.

On Demand Registration Fees

  • Physicians (MDs, PhDs, and DOs): $300
  • Advanced Practice Providers (NPs and PAs): $250
  • Pharmacists, Nurses and Other Healthcare Providers: $200
  • Fellows and Residents: $100
  • Industry Professionals*: $525

*Industry professionals may attend MSK CME activities for their own education. Marketing, sales, and promotion of products and services is strictly prohibited at MSK CME activities. For more information, please visit our Help page.

Registration Discounts/Promotions

  • A registration discount is available for MSK Alumni, MSK Cancer Alliance, and Cancer Care Partners to attend a MSK CME course. If you are a member of one of these groups, contact [email protected] for details.
  • Registration is complimentary for all MSK employees; however, you must complete registration through the 'Register' tab above in order to attend this course. If you are registered for this course and are unable to attend, please notify [email protected].

After your payment has been processed, no further promotional discounts or adjustments will be made to your registration.

Registration for this MSK CME on demand course is non-refundable.


Accreditation

Memorial Sloan Kettering Cancer Center is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

AMA Credit Designation Statement

Memorial Sloan Kettering Cancer Center designates this enduring material activity for a maximum of 6.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

ABIM MOC Recognition Statement

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 6.75 Medical Knowledge MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

 

Recorded/Review Date: October 9, 2020; Original Release Date: February 15, 2021; Termination Date: December 31, 2021